Gene regulatory and gene editing tools and their applications for retinal diseases and neuroprotection: From proof-of-concept to clinical trial.

Saved in:

Bibliographic Details
Title:	Gene regulatory and gene editing tools and their applications for retinal diseases and neuroprotection: From proof-of-concept to clinical trial.
Authors:	Altay HY; Molecular Biology, Genetics and Bioengineering Program, Sabanci University, Istanbul, Turkey., Ozdemir F; Molecular Biology, Genetics and Bioengineering Program, Sabanci University, Istanbul, Turkey., Afghah F; Molecular Biology, Genetics and Bioengineering Program, Sabanci University, Istanbul, Turkey., Kilinc Z; Molecular Biology, Genetics and Bioengineering Program, Sabanci University, Istanbul, Turkey., Ahmadian M; Molecular Biology, Genetics and Bioengineering Program, Sabanci University, Istanbul, Turkey., Tschopp M; Department of Ophthalmology, Cantonal Hospital Aarau, Aarau, Switzerland.; Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Agca C; Molecular Biology, Genetics and Bioengineering Program, Sabanci University, Istanbul, Turkey.; Nanotechnology Research and Application Center (SUNUM), Sabanci University, Istanbul, Turkey.
Source:	Frontiers in neuroscience [Front Neurosci] 2022 Oct 20; Vol. 16, pp. 924917. Date of Electronic Publication: 2022 Oct 20 (Print Publication: 2022).
Publication Type:	Journal Article; Review
Journal Info:	Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101478481 Publication Model: eCollection Cited Medium: Print ISSN: 1662-4548 (Print) Linking ISSN: 1662453X NLM ISO Abbreviation: Front Neurosci Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1662-4548
DOI:	10.3389/fnins.2022.924917